289 related articles for article (PubMed ID: 23271362)
1. Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: a meta-analysis.
Zhang RC; Mou SH
Tumour Biol; 2013 Apr; 34(2):901-7. PubMed ID: 23271362
[TBL] [Abstract][Full Text] [Related]
2. Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.
Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
Medicine (Baltimore); 2014 Dec; 93(29):e330. PubMed ID: 25546681
[TBL] [Abstract][Full Text] [Related]
3. Common polymorphisms in the XPD and hOGG1 genes are not associated with the risk of colorectal cancer in a Polish population.
Sliwinski T; Krupa R; Wisniewska-Jarosinska M; Pawlowska E; Lech J; Chojnacki J; Blasiak J
Tohoku J Exp Med; 2009 Jul; 218(3):185-91. PubMed ID: 19561388
[TBL] [Abstract][Full Text] [Related]
4. Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia.
Ban EZ; Lye MS; Chong PP; Yap YY; Lim SYC; Abdul Rahman H
PLoS One; 2017; 12(11):e0187200. PubMed ID: 29121049
[TBL] [Abstract][Full Text] [Related]
5. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.
Letkova L; Matakova T; Musak L; Sarlinova M; Krutakova M; Slovakova P; Kavcova E; Jakusova V; Janickova M; Drgova A; Berzinec P; Halasova E
Mol Biol Rep; 2013 Sep; 40(9):5261-73. PubMed ID: 23673479
[TBL] [Abstract][Full Text] [Related]
6. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
[TBL] [Abstract][Full Text] [Related]
7. XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies.
Ding DP; Ma WL; He XF; Zhang Y
Mol Biol Rep; 2012 Mar; 39(3):2533-40. PubMed ID: 21667112
[TBL] [Abstract][Full Text] [Related]
8. No association between hOGG1 Ser326Cys polymorphism and hepatocellular carcinoma.
Zhen-Bo T; An-Lin F; Ling L; Su-Fang Z
Hepatogastroenterology; 2013; 60(125):1101-4. PubMed ID: 23186590
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis.
Zhu S; Zhang H; Tang Y; Wang J
Urol Int; 2012; 89(2):233-40. PubMed ID: 22890093
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of xeroderma pigmentosum gene D Ls751Gln polymorphism and susceptibility to hepatocellular carcinoma.
Wang Y; Zhao Y; Zhang A; Ma J; Wang Z; Zhang X
Int J Clin Exp Pathol; 2015; 8(10):12949-54. PubMed ID: 26722489
[TBL] [Abstract][Full Text] [Related]
11. XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk.
Long XD; Ma Y; Zhou YF; Yao JG; Ban FZ; Huang YZ; Huang BC
BMC Cancer; 2009 Nov; 9():400. PubMed ID: 19919686
[TBL] [Abstract][Full Text] [Related]
12. [Association of the xeroderma pigmentosum group D DNA repair gene with hepatocellular carcinoma].
Zhang JJ; Ma JZ
Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):683-7. PubMed ID: 23207233
[TBL] [Abstract][Full Text] [Related]
13. XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
Cui J; Li D; Shen L; Zhang W; Xu X
Tumour Biol; 2014 Jul; 35(7):6335-41. PubMed ID: 24652592
[TBL] [Abstract][Full Text] [Related]
14. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies.
Yin QH; Liu C; Hu JB; Meng RR; Li L; Wang YJ
Asian Pac J Cancer Prev; 2013; 14(1):231-6. PubMed ID: 23534729
[TBL] [Abstract][Full Text] [Related]
15. hOGG1 Ser326Cys polymorphism and risk of hepatocellular carcinoma among East Asians: a meta-analysis.
Wang W; Dang S; Li Y; Sun M; Jia X; Wang R; Liu J
PLoS One; 2013; 8(4):e60178. PubMed ID: 23577090
[TBL] [Abstract][Full Text] [Related]
16. XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis.
Guo XF; Wang J; Lei XF; Zeng YP; Dong WG
Intern Med; 2015; 54(3):251-9. PubMed ID: 25748732
[TBL] [Abstract][Full Text] [Related]
17. XPD Lys
Yang QI; Wei YF; Zhang Y; Huang GM
Exp Ther Med; 2015 Jun; 9(6):2406-2414. PubMed ID: 26136996
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
Zhang Y; Ding D; Wang X; Zhu Z; Huang M; He X
Int J Colorectal Dis; 2011 Oct; 26(10):1257-64. PubMed ID: 21541661
[TBL] [Abstract][Full Text] [Related]
19. Association between the hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis based on 22,475 subjects.
Xu Z; Yu L; Zhang X
Diagn Pathol; 2013 Aug; 8():144. PubMed ID: 23971971
[TBL] [Abstract][Full Text] [Related]
20. Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects.
Lin H; Lin D; Zheng C
Diagn Pathol; 2014 Jan; 9():15. PubMed ID: 24443924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
